US equities
|
NVDA
$130.62
▼-10.52%
ANT
$87.81
▼-9.63%
MU
$602.16
▼-12.79%
AMD
$425.94
▼-12.93%
AAPL
$343.40
▼-1.66%
SPCX
$129.22
▼-6.65%
MSFT
$487.90
▼-2.09%
AMZN
$247.85
▼-3.70%
NVDA
$130.62
▼-10.52%
ANT
$87.81
▼-9.63%
MU
$602.16
▼-12.79%
AMD
$425.94
▼-12.93%
AAPL
$343.40
▼-1.66%
SPCX
$129.22
▼-6.65%
MSFT
$487.90
▼-2.09%
AMZN
$247.85
▼-3.70%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
bioAffinity Technologies, Inc. - Warrant
(NQ:
BIAFW
)
0.1505
-0.0013 (-0.86%)
Delayed Quote
Updated: 9:30 AM EST, Nov 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about bioAffinity Technologies, Inc. - Warrant
< Previous
1
2
3
4
5
Next >
bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference
September 07, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update
August 14, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer
July 12, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium
June 15, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Presents Research Findings at CYTO 2023
May 22, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer
May 01, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium
April 25, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results
March 31, 2023
From
bioAffinity Technologies, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
September 02, 2022
We're starting off the final trading day of the week with an overview of the biggest pre-market stock movers for Friday!
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >